• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

马来西亚骨质疏松症预防满意度调查问卷的编制与验证

The development and validation of the Satisfaction Questionnaire for Osteoporosis Prevention in Malaysia.

作者信息

Toh Li Shean, Lai Pauline Siew Mei, Wu David Bin-Chia, Wong Kok Thong, Low Bee Yean, Tan Alexander Tong Boon, Anderson Claire

机构信息

School of Pharmacy, University of Nottingham, Semenyih, Malaysia.

Department of Primary Care Medicine, University of Malaya Primary Care Research Group, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

Patient Prefer Adherence. 2014 Sep 30;8:1365-81. doi: 10.2147/PPA.S65718. eCollection 2014.

DOI:10.2147/PPA.S65718
PMID:25328386
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4199657/
Abstract

PURPOSE

To develop and validate the English version of the Satisfaction Questionnaire for Osteoporosis Prevention (SQOP) in Malaysia.

METHODS

The SQOP was modified from the Osteoporosis Patient Satisfaction Questionnaire and developed based on literature review and patient interviews. Face and content validity were established via an expert panel. The SQOP consists of two sections: clinical services and types of counseling. There were 23 items in total, each with a five-point Likert-type response. Satisfaction score was calculated by converting the total score to a percentage. A higher score indicates higher satisfaction. English speaking, non-osteoporotic, postmenopausal women aged ≥50 years were included in the study. Participants were randomized to either the control or intervention group. Intervention participants were provided counseling, whereas control participants received none. Participants answered the SQOP at baseline and 2 weeks later.

RESULTS

A total of 140 participants were recruited (control group: n=70; intervention group: n=70). No significant differences were found in any demographic aspects. Exploratory factor analysis extracted seven domains. Cronbach's α for the domains ranged from 0.531-0.812. All 23 items were highly correlated using Spearman's correlation coefficient 0.469-0.996 (P<0.05), with no significant change in the control group's overall test-retest scores, indicating that the SQOP achieved stable reliability. The intervention group had a higher score than the control group (87.91±5.99 versus 61.87±8.76; P<0.05), indicating that they were more satisfied than control participants. Flesch reading ease was 62.9.

CONCLUSION

The SQOP was found to be a valid and reliable instrument for assessing patients' satisfaction towards an osteoporosis screening and prevention service in Malaysia.

摘要

目的

开发并验证马来西亚版骨质疏松症预防满意度调查问卷(SQOP)的英文版本。

方法

SQOP是在骨质疏松症患者满意度调查问卷的基础上修改而成,基于文献综述和患者访谈进行开发。通过专家小组确定了表面效度和内容效度。SQOP由两个部分组成:临床服务和咨询类型。共有23个项目,每个项目采用五点李克特量表式回答。满意度得分通过将总分转换为百分比来计算。得分越高表明满意度越高。纳入研究的是年龄≥50岁、讲英语、非骨质疏松症的绝经后女性。参与者被随机分为对照组或干预组。干预组参与者接受咨询,而对照组参与者不接受咨询。参与者在基线时和2周后回答SQOP。

结果

共招募了140名参与者(对照组:n = 70;干预组:n = 70)。在任何人口统计学方面均未发现显著差异。探索性因素分析提取了七个领域。各领域的Cronbach's α系数范围为0.531 - 0.812。使用Spearman相关系数0.469 - 0.996(P < 0.05),所有23个项目高度相关,对照组的总体重测分数无显著变化,表明SQOP具有稳定的信度。干预组的得分高于对照组(87.91±5.99对61.87±8.76;P < 0.05),表明他们比对照组参与者更满意。弗莱什易读性为62.9。

结论

发现SQOP是评估马来西亚患者对骨质疏松症筛查和预防服务满意度的有效且可靠的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f0/4199657/18d43fc69fc8/ppa-8-1365Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f0/4199657/18d43fc69fc8/ppa-8-1365Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15f0/4199657/18d43fc69fc8/ppa-8-1365Fig1.jpg

相似文献

1
The development and validation of the Satisfaction Questionnaire for Osteoporosis Prevention in Malaysia.马来西亚骨质疏松症预防满意度调查问卷的编制与验证
Patient Prefer Adherence. 2014 Sep 30;8:1365-81. doi: 10.2147/PPA.S65718. eCollection 2014.
2
Cross-Cultural Adaptation and Validation of the Malay Satisfaction Questionnaire for Osteoporosis Prevention in Malaysia.马来西亚骨质疏松症预防马来语满意度问卷的跨文化适应与验证
Patient Prefer Adherence. 2021 Jun 23;15:1383-1395. doi: 10.2147/PPA.S314641. eCollection 2021.
3
The Development and Validation of the Osteoporosis Prevention and Awareness Tool (OPAAT) in Malaysia.马来西亚骨质疏松症预防与认知工具(OPAAT)的开发与验证
PLoS One. 2015 May 4;10(5):e0124553. doi: 10.1371/journal.pone.0124553. eCollection 2015.
4
Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ).骨质疏松症患者满意度问卷(OPSQ)的制定与验证。
Maturitas. 2010 Jan;65(1):55-63. doi: 10.1016/j.maturitas.2009.10.006. Epub 2009 Dec 4.
5
Development and validation of an Ambulatory Care Patient Satisfaction Questionnaire to assess pharmacy services in Malaysia.用于评估马来西亚药房服务的门诊护理患者满意度调查问卷的开发与验证。
Int J Clin Pharm. 2018 Oct;40(5):1309-1316. doi: 10.1007/s11096-018-0721-x. Epub 2018 Aug 29.
6
The development and validation of the advance care planning questionnaire in Malaysia.马来西亚预先护理计划问卷的开发与验证
BMC Med Ethics. 2016 Oct 18;17(1):61. doi: 10.1186/s12910-016-0147-8.
7
The validity and reliability of the Malaysian Osteoporosis Knowledge Tool in postmenopausal women.马来西亚骨质疏松症知识工具在绝经后女性中的有效性和可靠性。
Maturitas. 2008 Jun 20;60(2):122-30. doi: 10.1016/j.maturitas.2008.04.006. Epub 2008 May 27.
8
Development and validation of the Evidence Based Medicine Questionnaire (EBMQ) to assess doctors' knowledge, practice and barriers regarding the implementation of evidence-based medicine in primary care.开发并验证循证医学问卷(EBMQ),以评估医生在初级保健中实施循证医学方面的知识、实践情况和障碍。
BMC Fam Pract. 2018 Jun 23;19(1):98. doi: 10.1186/s12875-018-0779-5.
9
Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.ECOS-16问卷意大利语版本在患有骨质疏松症所致椎体骨折的绝经后女性中的效度和信度
Clin Exp Rheumatol. 2007 May-Jun;25(3):390-403.
10
Development and validation of an instrument to assess the prescribing readiness of medical students in Malaysia.用于评估马来西亚医学生处方准备情况的工具的开发与验证。
BMC Med Educ. 2015 Sep 21;15:153. doi: 10.1186/s12909-015-0433-z.

引用本文的文献

1
Cross-Cultural Adaptation and Validation of the Malay Satisfaction Questionnaire for Osteoporosis Prevention in Malaysia.马来西亚骨质疏松症预防马来语满意度问卷的跨文化适应与验证
Patient Prefer Adherence. 2021 Jun 23;15:1383-1395. doi: 10.2147/PPA.S314641. eCollection 2021.
2
Feasibility of an interprofessional collaborative osteoporosis screening programme in Malaysia.
Int J Clin Pharm. 2020 Feb;42(1):11-17. doi: 10.1007/s11096-019-00960-x. Epub 2020 Mar 27.
3
Development and validation of an Ambulatory Care Patient Satisfaction Questionnaire to assess pharmacy services in Malaysia.用于评估马来西亚药房服务的门诊护理患者满意度调查问卷的开发与验证。

本文引用的文献

1
Impact of pharmaceutical care on knowledge, quality of life and satisfaction of postmenopausal women with osteoporosis.药学服务对骨质疏松症绝经后妇女知识、生活质量和满意度的影响。
Int J Clin Pharm. 2013 Aug;35(4):629-37. doi: 10.1007/s11096-013-9784-x. Epub 2013 May 16.
2
Development, reliability, and validity of a new Preference and Satisfaction Questionnaire.新偏好和满意度问卷的开发、可靠性和有效性。
Value Health. 2011 Dec;14(8):1109-16. doi: 10.1016/j.jval.2011.06.010. Epub 2011 Oct 1.
3
Development and validation of the osteoporosis patient satisfaction questionnaire (OPSQ).
Int J Clin Pharm. 2018 Oct;40(5):1309-1316. doi: 10.1007/s11096-018-0721-x. Epub 2018 Aug 29.
4
Patient satisfaction with a chronic kidney disease risk assessment service in community pharmacies.社区药房慢性肾病风险评估服务的患者满意度
Int J Clin Pharm. 2018 Apr;40(2):458-463. doi: 10.1007/s11096-018-0603-2. Epub 2018 Feb 13.
骨质疏松症患者满意度问卷(OPSQ)的制定与验证。
Maturitas. 2010 Jan;65(1):55-63. doi: 10.1016/j.maturitas.2009.10.006. Epub 2009 Dec 4.
4
Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial.社区药剂师主导的骨质疏松症筛查计划:随机对照试验。
Osteoporos Int. 2010 Mar;21(3):391-8. doi: 10.1007/s00198-009-0977-z. Epub 2009 Jun 5.
5
Measuring patient satisfaction with diabetes disease state management services in community pharmacy.衡量患者对社区药房糖尿病疾病状态管理服务的满意度。
Res Social Adm Pharm. 2009 Mar;5(1):31-9. doi: 10.1016/j.sapharm.2008.05.006.
6
Orthopaedic management improves the rate of early osteoporosis treatment after hip fracture. A randomized clinical trial.骨科治疗可提高髋部骨折后早期骨质疏松症的治疗率。一项随机临床试验。
J Bone Joint Surg Am. 2008 Nov;90(11):2346-53. doi: 10.2106/JBJS.G.01246.
7
A new readability yardstick.一种新的可读性衡量标准。
J Appl Psychol. 1948 Jun;32(3):221-33. doi: 10.1037/h0057532.
8
Improving evaluation and treatment for osteoporosis following distal radial fractures. A prospective randomized intervention.改善桡骨远端骨折后骨质疏松症的评估与治疗。一项前瞻性随机干预研究。
J Bone Joint Surg Am. 2008 May;90(5):953-61. doi: 10.2106/JBJS.G.01121.
9
Use of a case manager to improve osteoporosis treatment after hip fracture: results of a randomized controlled trial.使用病例管理员改善髋部骨折后的骨质疏松症治疗:一项随机对照试验的结果
Arch Intern Med. 2007 Oct 22;167(19):2110-5. doi: 10.1001/archinte.167.19.2110.
10
Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women.骨质疏松症患者治疗满意度问卷(OPSAT-Q)的心理测量学评估,这是一种评估绝经后妇女对双膦酸盐治疗满意度的新方法。
Health Qual Life Outcomes. 2006 Jul 11;4:42. doi: 10.1186/1477-7525-4-42.